DEPARTMENT PROFILE

Lloreda Camacho & Co

Life Sciences

3 ranked lawyers

Band 1

Colombia

Latin America 2022 View ranking table

chambers review

department information

Ranked Lawyers

Chambers Review

Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.

What the team is known for

Front-running practice possessing outstanding capabilities across the life sciences arena. Boasts considerable experience advising clients on regulatory matters, including sanitary registration, marketing authorisation and pricing issues, as well as data exclusivity and clinical trials. Active representing clients before INVIMA. Practice group boasts a stellar client roster of prominent international pharmaceutical, medical devices and biotechnology companies.

Strengths

One client describes the service as "excellent," adding: "Their advice is always precise and clear and their approach to our work is always very innovative, which allows us to implement their strategy confidently and assuredly."

Another client reports: "Lloreda Camacho & Co offers high-quality support, as well as a team of experts in the healthcare sector." They also say: "They have a good understanding of our business and their lawyers have a very good business acumen."

Work highlights

Lloreda Camacho & Co advised Boehringer Ingelheim on submissions before the INVIMA, including matters related to patient support programmes, data exclusivity protection and clinical trials, as well as administrative procedures regarding pricing investigations.

Notable practitioners

Market-leading heavyweight Ana María Castro "is an internationally recognised expert in the regulatory field," according to an interviewee, who adds: "She has a broad knowledge of the life sciences industry in Colombia and across Latin America, and is clearly a leading light in the region." A market observer further appreciates that "she is a national reference in this area, who stands out for her work advising pharmaceutical companies." Ana María Castro is co-head of department.

Daniel Cardona "offers a comprehensive knowledge of the relevant legislation covering the pharmaceutical industry," a client extols, while another interviewee appreciates his "personalised service, professionalism and high-quality work."

A market commentator highlights Enrique Álvarez Posada for handling a wide range of patent mandates for clients from the pharmaceutical industry, and describes him as "a very good lawyer." Another interviewee adds: "He is an expert in the industry who offers impeccable advice." Enrique Álvarez Posada is co-head of Lloreda Camacho & Co's life sciences department.

Department Information

This content is provided by Lloreda Camacho & Co.

Overview

We represent major R&D pharmaceutical, biotechnology, medical device, food, beverage and cosmetics local and foreign companies in Colombia. We counsel our clients on a full range of regulatory issues and patent matters at every stage of their products life cycle, including structuring strategies for Marketing Authorization (preparation and prosecution of applications for health registrations, renewals, modifications, certifications and authorizations with INVIMA that is the National Regulatory Agency in Colombia); Promotional Practices; and Post-Marketing Safety Plans and the prosecution and enforcement of their patents.

Our life sciences team is also specialized and well-known for its active patent practice in the biopharmaceutical sector in the Latin America Region, e.g. managing some of our clients’ patents portfolio in all Latin American countries and Caribbean.

One of the major focuses of our health department is to provide complete legal counsel in all matters such as data protection, registration procedures, clinical studies, compliance investigations, marketing activities, advertising, price regulation, investigations for alleged health regulation, labeling, among others.

We are also deeply involved in the different legal strategies for the implementation of biotechnological decree 1782.